ESCITALOPRAM: cost and payments to doctors
What Medicare Part D paid pharmacies for ESCITALOPRAM, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Part D cost for ESCITALOPRAM formulations
Medicare reports ESCITALOPRAM under its specific formulations, which are priced separately.
- escitalopram oxalate$6per 30-day fill · 11,933,148 claims · Escitalopram Oxalate
Paid to pharmacies by Part D plans and patients — not your cost, and not paid to the prescriber. Is this wrong?
Was your doctor paid by H. Lundbeck A S?
H. Lundbeck A S reported the most payments naming ESCITALOPRAM. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $86K
- Providers
- 7
- Transactions
- 39
- Average per transaction
- $2,215
The per-transaction average — $2,215 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7 providers the average total is $12,340, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| H. Lundbeck A S | $86,361 | 100.0% |
| Almatica Pharma LLC | $17 | 0.0% |
Other products from H. Lundbeck A S
The company that reported the most payments naming ESCITALOPRAM also reports against these.
- VYEPTI$1,443,619
- REXULTI$1,182,256
- ABILIFY MAINTENA$969,709
- BRINTELLIX$693,200
- EPTINEZUMAB$19,230
- NORTHERA$13,851
- RASAGILINE$1,697